COVID-19 RAPID ANTIGEN TEST
The INDICAID™ COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for the objective identification of SARS-CoV-2 antigens. Antigen tests are designed to detect proteins from the virus that causes COVID-19 through swab specimens taken from a patient’s nose.
YOUR RELIABLE INDICATOR FOR COVID-19
RESULTS IN 20 MINUTES
BATCH-COLLECTING AND BULK-TESTING SAMPLES
NO EQUIPMENT OR TRAINING NECESSARY
GENTLE SELF-COLLECTION WITH SHALLOW, NASAL SAMPLES
BULK-TESTING OF INDIVIDUAL SAMPLES
INDICAID’s intuitive vial design allows for the aggregate collection of multiple specimens followed by batch-testing of individual samples up to two (2) hours after collection.
- You have COVID-19 symptoms
- You feel the need to self-quarantine
- You need to make travel decisions
- You need to make health decisions
- You need to make school/work decisions
- You want to protect others
QUICK & EASY TESTING
We supply fast reliable tests for clinics, employers, education, events & more.
The US FDA has extended their emergency use authorization (EUA) for the INDICAID™ COVID-19 Rapid Antigen Test to cover serial testing for asymptomatic individuals in a recent update. The update extends the use of INDICAID™ as a screening test, providing an additional accurate and reliable testing option for schools, workplaces, and communities.
“It busts the myth that antigen tests could only detect symptomatic patients and shows that high-quality antigen tests can be sensitive, accurate, and reliable to be used for population screening.”
Product performance against new variants are evaluated on an ongoing basis.
New sensitivity – 88.9 %
PHASE Scientiﬁc is a high-growth biotech company founded by bioengineers from UCLA. We build tools that empower people by giving them better information about their health. Now headquartered in Hong Kong, our global footprint includes R&D and manufacturing facilities in Southern California and ofﬁces in Mainland China.
WITH SUPPORT FROM
AS SEEN IN